denifanstat
SB2640-CLIN-011
Phase 3 small_molecule terminated
Quick answer
denifanstat for MASLD is a Phase 3 program (small_molecule) at Sagimet Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sagimet Biosciences
- Indication
- MASLD
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated